Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity and related diseases.
San Francisco & Shanghai
Joined August 2021
- Tweets177
- Following150
- Followers415
- Likes12
Structure Therapeutics retweeted
"We can make enough material for more than 100 million people..."
@StructureTx CEO Ray Stevens speaks about what his company's new oral GLP-1 drug brings to the crowded marketplace:
Structure Therapeutics retweeted
Structural Biology-Driven Drug Discovery: Ray Stevens, CEO of @ShouTiPharma on The Long Run. timmermanreport.com/2022/03/…
Structure Therapeutics retweeted
@ShouTiPharma @SentiBio @GenomeMed @zipline @KellerRinaudo @keenanwyrobek @MazeInBiotech @ercgrn @insitro @freenome @GabeOtte @plenty Congrats on being featured in our 2022 Best Tech Startups in South San Francisco! thetechtribune.com/best-tech…
Structure Therapeutics retweeted
How a China-Peninsula company hopes to turn biologics into simple-to-take pills (Hint, it involves a $100M Series B round) bizjournals.com/sanfrancisco…
Structure Therapeutics retweeted
ShouTi, a Schrödinger-partnered startup, uncloaked Wednesday morning with a hefty Series B round. The team is targeting G-protein coupled receptors — a class of tiny but integral membrane proteins that remains largely unexplored.
endpts.com/a-new-schrodinger…
Structure Therapeutics retweeted
“I think the pendulum has swung very far in terms of companies have been developing more and more biologics. That creates a real opportunity globally to be able to convert them into small molecules and make them accessible to all" fiercebiotech.com/biotech/re…
Structure Therapeutics retweeted
Small molecules that work like biologic & peptide drugs? #Biotech #startup @ShouTiPharma aims to make it happen. It just raised $100M for R&D of drugs for #chronicdiseases; initial focus is cardio/pulmonary & #metabolicdisorders medcitynews.com/2021/10/shou…